OptiBiotix Health (LON:OPTI) Share Price Passes Below Fifty Day Moving Average – Time to Sell?

OptiBiotix Health Plc (LON:OPTI) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 6.03 and traded as low as GBX 5.60. OptiBiotix Health shares last traded at GBX 5.94, with a volume of 466,493 shares.

OptiBiotix Health Stock Down 2.6%

The stock has a fifty day moving average of GBX 6 and a two-hundred day moving average of GBX 5.92. The stock has a market cap of £5.78 million, a price-to-earnings ratio of -1.46 and a beta of 1.82.

OptiBiotix Health (LON:OPTI) last released its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) EPS for the quarter. The firm had revenue of GBX 117 million during the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.

Insider Buying and Selling

In other OptiBiotix Health news, insider David Blain purchased 158,965 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were purchased at an average price of GBX 6 per share, for a total transaction of £9,537.90. Insiders own 26.79% of the company’s stock.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.